Lucille Revillod

Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice

G. Bassez, J. Puymirat, S. Pandey, 2017, Molecular therapy. Nucleic acids.